A. Nationale-de-sécurité-du-médicament, ANSM) ; les anticoagulants en France en 2012: Etat des lieux et surveillance

O. Kandel, D. Duhot, G. Very, J. Lemasson, and P. Boisnault, Existe-t-il une typologie des actes éffectués en médecine générale ?, La revue du praticien, vol.18, pp.781-784, 2004.

J. Douketis, Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians, Thrombosis Research, vol.108, issue.1, pp.3-13, 2002.
DOI : 10.1016/S0049-3848(02)00387-0

G. Pernod, T. Lecompte, I. Gouin-thibault, and P. Albaladejo, Surgery and invasive procedures in patient on long-term treatment with oral direct thrombin or factor Xa inhibitors. Annale Françaises d'anesthésie et de, Réanimation, vol.30, pp.645-650, 2011.

P. Camm and . Kirchhof, European Heart Rhythm Association. Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation, European Heart Journal, vol.15, pp.625-651, 2013.

A. S. Dunn and A. Turpie, Perioperative Management of Patients Receiving Oral Anticoagulants, Archives of Internal Medicine, vol.163, issue.8, pp.901-908, 2003.
DOI : 10.1001/archinte.163.8.901

M. Ezekowitz and S. Connolly, Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran, American Heart Journal, vol.157, issue.5, pp.805-815, 2009.
DOI : 10.1016/j.ahj.2009.02.005

S. Schulman, C. Kearon, A. Kakkar, P. Mismetti, S. Schellong et al., Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism, New England Journal of Medicine, vol.361, issue.24, pp.2342-2352, 2009.
DOI : 10.1056/NEJMoa0906598

URL : https://hal.archives-ouvertes.fr/ujm-00439704

J. Stangier, Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran Etexilate, Clinical Pharmacokinetics, vol.5, issue.1, pp.285-295, 2008.
DOI : 10.2165/00003088-200847050-00001

K. A. Berkowitz, R. M. Fox, and . Califf, Rivaroxaban Once daily oral direct Factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and embolism Trial in Atrial Fibrillation, N Eng J Med, vol.365, pp.883-891, 2011.

R. Bauersechs, S. Berkowitz, B. Brener, H. Buller, H. Decousus et al., Oral rivaroxban for symptomatic venous thromboembolism, N Engl J Med, vol.363, pp.2499-2510, 2010.

G. Pernod, A. Elias, I. Gouin, C. Gaillard, P. Nguyen et al., Questions???????r??ponses sur l???utilisation du rivaroxaban pour le traitement de la maladie thromboembolique veineuse, Journal des Maladies Vasculaires, vol.37, issue.6, pp.300-310, 2012.
DOI : 10.1016/j.jmv.2012.09.003

A. Tripodi, V. Chantarangkul, C. Guinet, and M. Samama, The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban-treated patients: results of an in??vitro study, Journal of Thrombosis and Haemostasis, vol.8, issue.1, pp.226-228, 2011.
DOI : 10.1111/j.1538-7836.2010.04106.x

W. Ageno, A. Gallus, A. Wittkowsky, M. Crowther, E. Hylek et al., Oral Anticoagulant Therapy, Chest, vol.141, issue.2, pp.44-88, 2012.
DOI : 10.1378/chest.11-2292

G. Lu, F. De-guzman, S. Lakhotia, S. Hollenbach, D. Phillips et al., Recombinant antidote for reversal of anticoagulation by factor Xa inhibitors, Blood, vol.112, 2008.

R. Marlu, E. Hodaj, A. Paris, P. Albaladejo, J. Crackowski et al., Effect of nonspecific reversal agents on anticoagulant activity of dabigatran and rivaroxaban. A randomised crossover ex vivo study in healthy volunteers, Thromb Haemost, 2012.

R. Lug, F. Deguzman, S. J. Hollenbach, M. J. Karbarz, K. Abe et al., A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa, Nature medicine, vol.19, pp.446-453, 2013.

J. Van-ryn, T. Litzenburger, A. Waterman, K. Canada, N. Hauel et al., DABIGATRAN ANTICOAGULANT ACTIVITY IS NEUTRALIZED BY AN ANTIBODY SELECTIVE TO DABIGATRAN IN IN VITRO AND IN VIVO MODELS, Journal of the American College of Cardiology, vol.57, issue.14, 1130.
DOI : 10.1016/S0735-1097(11)61130-3

J. Van-ryn, J. Stangier, S. Haerter, K. Liesenfield, W. Wienen et al., Dabigatran etexilate ??? a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity, Thrombosis and Haemostasis, vol.103, issue.6, pp.1116-1127, 2010.
DOI : 10.1160/TH09-11-0758

M. Elg, S. Carlson, and D. Gustafsson, Effects of Agents, Used to Treat Bleeding Disorders, on Bleeding Time Prolonged by a Very High Dose of a Direct Thrombin Inhibitor in Anesthesized Rats and Rabbits, Thrombosis Research, vol.101, issue.3, pp.159-170, 2001.
DOI : 10.1016/S0049-3848(00)00398-4

K. Vavra, M. Lutz, and M. Smythe, Recombinant Factor VIIa to Manage Major Bleeding from Newer Parenteral Anticoagulants, Annals of Pharmacotherapy, vol.44, issue.4, pp.718-726, 2010.
DOI : 10.1345/aph.1M447

M. Levi, J. Levy, H. Andersen, and D. Truloff, Safety of Recombinant Activated Factor VII in Randomized Clinical Trials, New England Journal of Medicine, vol.363, issue.19, pp.1791-1800, 2010.
DOI : 10.1056/NEJMoa1006221

G. Freyburger, G. Macouillard, S. Labrouche, and F. Sztark, Coagulation parameters in patients receiving dabigatran etexilate or rivaroxaban: Two observational studies in patients undergoing total hip or total knee replacement, Thrombosis Research, vol.127, issue.5, pp.455-467, 2011.
DOI : 10.1016/j.thromres.2011.01.001

J. Alcalay and R. Alkalay, Controversies in Perioperative Management of Blood Thinners in Dermatologic Surgery, Dermatologic Surgery, vol.30, issue.8, pp.1091-1094, 2004.
DOI : 10.1097/00042728-200408000-00005

C. Otley, J. Fewkes, W. Franck, and S. Olbricht, Complications of Cutaneous Surgery in Patients Who Are Taking Warfarin, Aspirin, or Nonsteroidal Anti-inflammatory Drugs, Archives of Dermatology, vol.132, issue.2, pp.161-166, 1996.
DOI : 10.1001/archderm.1996.03890260063009

E. Billingsley and M. Maloney, Intraoperative and postoperative bleeding problems in patients taking warfarin, aspirin and nonsteroidal anti-inflammatory agents: a prospective study, Dermatol Surg, vol.23, pp.381-385, 1997.

D. Sautereau and J. Canard, Prise en charge des patients sous anticoagulants ou sous agents antiplaquettaires avant une endoscopie digestive, 2005.

L. Gerson, B. Gage, D. Owen, and G. Triadafilopolos, Effect and outcomes of the ASGE guidelines on the periendoscopic management of patients who take anticoagulants, The American Journal of Gastroenterology, vol.122, issue.7, pp.1717-1725, 2000.
DOI : 10.1056/NEJM199304013281301

G. Eisen and J. Dominitz, For American Society for Gastrointestinal Endoscopy

C. Woodhouse, G. Evans, and A. Muller, The new oral anticoagulants: practical management for patients attending for endoscopic procedures, Frontline Gastroenterology, vol.107, issue.3, pp.213-218, 2013.
DOI : 10.1136/flgastro-2013-100325

G. De-mello, P. Ganglof, P. Djiane, J. Galeazzi, B. Iung et al., Recommandation pour la prise en charge des patients sous AVK en chirurgie bucco-dentaire, Médecine buccale chirurgie buccale, vol.12, pp.187-206, 2006.

C. Boureau, Y. Ounnoughene, M. Coudray, and C. Mesner, chirurgie de la cataracte sous anticoagulant ou antiagrégant : anesthésie topique et sous tenonienne, J Fr Ophtalmol, vol.25, pp.130-132, 2002.

O. Fleisher and . Schein, Risks and Benefits of Anticoagulant and Antiplatelet Medication Use before Cataract Surgery, Ophtalmology, vol.110, pp.1784-1788, 2003.

K. Carter and K. Miller, Phacoemulsification and lens implantation in patients treated with aspirin or warfarin, Journal of Cataract & Refractive Surgery, vol.24, issue.10, pp.1361-1364, 1998.
DOI : 10.1016/S0886-3350(98)80229-0

J. Thumboo and D. O. Duffy, A prospective study of the safety of joint and soft tissue aspirations and injections in patients taking warfarin sodium, Arthritis & Rheumatism, vol.27, issue.4, pp.736-739, 1998.
DOI : 10.1002/1529-0131(199804)41:4<736::AID-ART23>3.0.CO;2-P

V. Lemaire, B. Charbonnier, Y. Gruel, P. Goupelle, and J. Valat, Antiagr??gants, anticoagulants et infiltrations??: comment faire???, Revue du Rhumatisme, vol.69, issue.1, pp.8-11, 2002.
DOI : 10.1016/S1169-8330(01)00241-1